fanta.bio Sample: CNhs11953
17580 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1397 / 18302 (7.6%) | 380 / 183020 (0.2%) | −324.0 | −324.0 | 36.76 |
| TP53 SRX19538267 | U2OS Bone | 458 / 18302 (2.5%) | 139 / 183020 (0.1%) | −324.0 | −324.0 | 32.95 |
| TP53 SRX19538268 | U2OS Bone | 505 / 18302 (2.8%) | 159 / 183020 (0.1%) | −324.0 | −324.0 | 31.76 |
| TP53 SRX19538273 | U2OS Bone | 440 / 18302 (2.4%) | 144 / 183020 (0.1%) | −324.0 | −324.0 | 30.56 |
| TP53 SRX19538274 | U2OS Bone | 505 / 18302 (2.8%) | 166 / 183020 (0.1%) | −324.0 | −324.0 | 30.42 |
| TP53 SRX19538276 | U2OS Bone | 501 / 18302 (2.7%) | 166 / 183020 (0.1%) | −324.0 | −324.0 | 30.18 |
| HIF1A SRX11007095 | HK-2 Kidney | 2580 / 18302 (14.1%) | 869 / 183020 (0.5%) | −324.0 | −324.0 | 29.69 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 2039 / 18302 (11.1%) | 710 / 183020 (0.4%) | −324.0 | −324.0 | 28.72 |
| TP53 SRX19538275 | U2OS Bone | 452 / 18302 (2.5%) | 162 / 183020 (0.1%) | −324.0 | −324.0 | 27.90 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1932 / 18302 (10.6%) | 763 / 183020 (0.4%) | −324.0 | −324.0 | 25.32 |
| TP53 SRX19538280 | Osteoblasts Bone | 484 / 18302 (2.6%) | 196 / 183020 (0.1%) | −324.0 | −324.0 | 24.69 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 508 / 18302 (2.8%) | 208 / 183020 (0.1%) | −324.0 | −324.0 | 24.42 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2722 / 18302 (14.9%) | 1128 / 183020 (0.6%) | −324.0 | −324.0 | 24.13 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2624 / 18302 (14.3%) | 1113 / 183020 (0.6%) | −324.0 | −324.0 | 23.58 |
| TP53 SRX19538279 | Osteoblasts Bone | 616 / 18302 (3.4%) | 262 / 183020 (0.1%) | −324.0 | −324.0 | 23.51 |
| HIF1A SRX20663235 | HK-2 Kidney | 570 / 18302 (3.1%) | 261 / 183020 (0.1%) | −324.0 | −324.0 | 21.84 |
| SCML2 SRX644728 | 293 Kidney | 1613 / 18302 (8.8%) | 770 / 183020 (0.4%) | −324.0 | −324.0 | 20.95 |
| FOXP1 SRX736067 | LNCAP Prostate | 2182 / 18302 (11.9%) | 1182 / 183020 (0.6%) | −324.0 | −324.0 | 18.46 |
| TP53 SRX19538281 | Osteoblasts Bone | 527 / 18302 (2.9%) | 290 / 183020 (0.2%) | −324.0 | −324.0 | 18.17 |
| MYH11 SRX265221 | ME-1 Blood | 991 / 18302 (5.4%) | 620 / 183020 (0.3%) | −324.0 | −324.0 | 15.98 |
| BRD4 SRX9419935 | BT-474 Breast | 4200 / 18302 (22.9%) | 2798 / 183020 (1.5%) | −324.0 | −324.0 | 15.01 |
| BRD4 SRX9419937 | BT-474 Breast | 4204 / 18302 (23.0%) | 2875 / 183020 (1.6%) | −324.0 | −324.0 | 14.62 |
| MED1 SRX9419944 | BT-474 Breast | 4092 / 18302 (22.4%) | 2801 / 183020 (1.5%) | −324.0 | −324.0 | 14.61 |
| MED1 SRX9419945 | BT-474 Breast | 4111 / 18302 (22.5%) | 2855 / 183020 (1.6%) | −324.0 | −324.0 | 14.40 |
| BRD4 SRX9419936 | BT-474 Breast | 4233 / 18302 (23.1%) | 2981 / 183020 (1.6%) | −324.0 | −324.0 | 14.20 |
| BRD4 SRX9419938 | BT-474 Breast | 4213 / 18302 (23.0%) | 2993 / 183020 (1.6%) | −324.0 | −324.0 | 14.08 |
| MED1 SRX9419946 | BT-474 Breast | 4239 / 18302 (23.2%) | 3019 / 183020 (1.6%) | −324.0 | −324.0 | 14.04 |
| MED1 SRX9419947 | BT-474 Breast | 4110 / 18302 (22.5%) | 2957 / 183020 (1.6%) | −324.0 | −324.0 | 13.90 |
| EZH2 SRX2146136 | LNCAP Prostate | 9041 / 18302 (49.4%) | 8359 / 183020 (4.6%) | −324.0 | −324.0 | 10.82 |
| BRD4 SRX736201 | 90-8TL Neural | 7025 / 18302 (38.4%) | 6753 / 183020 (3.7%) | −324.0 | −324.0 | 10.40 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 847 / 18302 (4.6%) | 919 / 183020 (0.5%) | −324.0 | −324.0 | 9.22 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 807 / 18302 (4.4%) | 1016 / 183020 (0.6%) | −324.0 | −324.0 | 7.94 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 759 / 18302 (4.1%) | 956 / 183020 (0.5%) | −324.0 | −324.0 | 7.94 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2098 / 18302 (11.5%) | 2814 / 183020 (1.5%) | −324.0 | −324.0 | 7.46 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1758 / 18302 (9.6%) | 3843 / 183020 (2.1%) | −324.0 | −324.0 | 4.57 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1921 / 18302 (10.5%) | 5346 / 183020 (2.9%) | −324.0 | −324.0 | 3.59 |
| Epitope tags SRX10549776 | K-562 Blood | 1772 / 18302 (9.7%) | 5579 / 183020 (3.0%) | −324.0 | −324.0 | 3.18 |
| AGO2 SRX4708039 | Hep G2 Liver | 2330 / 18302 (12.7%) | 7972 / 183020 (4.4%) | −324.0 | −324.0 | 2.92 |
| PBX4 SRX2731658 | PC-3 Prostate | 991 / 18302 (5.4%) | 28739 / 183020 (15.7%) | −324.0 | −324.0 | 0.34 |
| 5-mC SRX882970 | LNCAP Prostate | 3376 / 18302 (18.4%) | 16247 / 183020 (8.9%) | −315.1 | −312.1 | 2.08 |
| FOS SRX150477 | MCF 10A Breast | 653 / 18302 (3.6%) | 21349 / 183020 (11.7%) | −314.2 | −311.3 | 0.31 |
| RUNX1 SRX2513054 | 293 Kidney | 3757 / 18302 (20.5%) | 19112 / 183020 (10.4%) | −311.5 | −308.6 | 1.97 |
| KAT7 SRX101303 | RKO Digestive tract | 1702 / 18302 (9.3%) | 5455 / 183020 (3.0%) | −310.3 | −307.4 | 3.12 |
| FOS SRX150478 | MCF 10A Breast | 698 / 18302 (3.8%) | 21948 / 183020 (12.0%) | −310.1 | −307.2 | 0.32 |
| 5-mC SRX882968 | LNCAP Prostate | 3334 / 18302 (18.2%) | 16142 / 183020 (8.8%) | −306.4 | −303.5 | 2.07 |
| TP53 SRX19538269 | U2OS Bone | 552 / 18302 (3.0%) | 444 / 183020 (0.2%) | −300.3 | −297.5 | 12.43 |
| IRF3 SRX11453858 | Hep G2 Liver | 361 / 18302 (2.0%) | 73 / 183020 (0.0%) | −296.2 | −293.4 | 49.45 |
| BRD1 SRX286203 | RKO Digestive tract | 1464 / 18302 (8.0%) | 4400 / 183020 (2.4%) | −289.2 | −286.3 | 3.33 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1035 / 18302 (5.7%) | 26388 / 183020 (14.4%) | −289.0 | −286.1 | 0.39 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 653 / 18302 (3.6%) | 20439 / 183020 (11.2%) | −285.5 | −282.6 | 0.32 |
| TP53 SRX19538270 | U2OS Bone | 524 / 18302 (2.9%) | 431 / 183020 (0.2%) | −282.1 | −279.3 | 12.16 |
| BRPF3 SRX796084 | RKO Digestive tract | 1825 / 18302 (10.0%) | 6577 / 183020 (3.6%) | −280.5 | −277.7 | 2.77 |
| BRPF3 SRX796086 | RKO Digestive tract | 1762 / 18302 (9.6%) | 6219 / 183020 (3.4%) | −279.3 | −276.5 | 2.83 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 608 / 18302 (3.3%) | 682 / 183020 (0.4%) | −278.8 | −276.0 | 8.91 |
| YAP1 SRX757325 | H2052 Lung | 780 / 18302 (4.3%) | 22175 / 183020 (12.1%) | −277.6 | −274.8 | 0.35 |
| BRPF3 SRX796085 | RKO Digestive tract | 1321 / 18302 (7.2%) | 3794 / 183020 (2.1%) | −275.5 | −272.7 | 3.48 |
| FOS SRX4192880 | MCF 10A Breast | 489 / 18302 (2.7%) | 17402 / 183020 (9.5%) | −275.2 | −272.4 | 0.28 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2409 / 18302 (13.2%) | 10381 / 183020 (5.7%) | −274.8 | −272.0 | 2.32 |
| FOXA1 SRX4815197 | MCF-7 Breast | 757 / 18302 (4.1%) | 21601 / 183020 (11.8%) | −271.0 | −268.3 | 0.35 |
| 5-mC SRX882965 | LNCAP Prostate | 2709 / 18302 (14.8%) | 12533 / 183020 (6.8%) | −269.4 | −266.7 | 2.16 |
| MEAF6 DRX234811 | 293 Kidney | 2024 / 18302 (11.1%) | 7995 / 183020 (4.4%) | −268.3 | −265.5 | 2.53 |
| FOXA1 SRX176862 | MCF-7 Breast | 374 / 18302 (2.0%) | 15163 / 183020 (8.3%) | −267.6 | −264.9 | 0.25 |
| BRD4 SRX736204 | 90-8TL Neural | 1147 / 18302 (6.3%) | 3006 / 183020 (1.6%) | −265.7 | −263.0 | 3.82 |
| TP53 SRX19538282 | Osteoblasts Bone | 448 / 18302 (2.4%) | 308 / 183020 (0.2%) | −260.8 | −258.1 | 14.55 |
| AGO2 SRX6783957 | Hep G2 Liver | 1468 / 18302 (8.0%) | 4819 / 183020 (2.6%) | −257.1 | −254.4 | 3.05 |
| YAP1 SRX757326 | H2052 Lung | 678 / 18302 (3.7%) | 19857 / 183020 (10.8%) | −255.6 | −252.9 | 0.34 |
| KAT6A SRX20971022 | Fibroblasts Others | 313 / 18302 (1.7%) | 66 / 183020 (0.0%) | −254.9 | −252.2 | 47.42 |
| MEAF6 DRX300417 | 293 Kidney | 1846 / 18302 (10.1%) | 7106 / 183020 (3.9%) | −254.6 | −251.9 | 2.60 |
| CIC SRX13262055 | Astrocytes Neural | 3413 / 18302 (18.6%) | 17996 / 183020 (9.8%) | −254.2 | −251.5 | 1.90 |
| FOXA1 SRX176863 | MCF-7 Breast | 359 / 18302 (2.0%) | 14406 / 183020 (7.9%) | −251.4 | −248.7 | 0.25 |
| ESR1 SRX7624157 | MCF-7 Breast | 857 / 18302 (4.7%) | 22387 / 183020 (12.2%) | −249.6 | −246.9 | 0.38 |
| FOS SRX150517 | MCF 10A Breast | 539 / 18302 (2.9%) | 17411 / 183020 (9.5%) | −249.0 | −246.3 | 0.31 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 584 / 18302 (3.2%) | 747 / 183020 (0.4%) | −247.2 | −244.5 | 7.82 |
| GATA3 SRX190239 | MCF-7 Breast | 461 / 18302 (2.5%) | 15968 / 183020 (8.7%) | −244.5 | −241.8 | 0.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 1418 / 18302 (7.7%) | 4707 / 183020 (2.6%) | −244.1 | −241.4 | 3.01 |
| IRF3 SRX11453861 | Hep G2 Liver | 305 / 18302 (1.7%) | 73 / 183020 (0.0%) | −242.3 | −239.7 | 41.78 |
| AR SRX10820653 | LNCAP Prostate | 385 / 18302 (2.1%) | 216 / 183020 (0.1%) | −242.3 | −239.7 | 17.82 |
| Epitope tags DRX443510 | 293 Kidney | 1726 / 18302 (9.4%) | 6605 / 183020 (3.6%) | −239.6 | −237.0 | 2.61 |
| FOXA1 SRX1161177 | MCF-7 Breast | 306 / 18302 (1.7%) | 13060 / 183020 (7.1%) | −238.6 | −236.0 | 0.23 |
| ESR1 SRX371478 | MCF-7 Breast | 407 / 18302 (2.2%) | 14826 / 183020 (8.1%) | −237.5 | −234.9 | 0.27 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1579 / 18302 (8.6%) | 5751 / 183020 (3.1%) | −236.9 | −234.3 | 2.75 |
| FOXA1 SRX3931044 | MCF-7 Breast | 728 / 18302 (4.0%) | 19972 / 183020 (10.9%) | −236.2 | −233.6 | 0.36 |
| FOXA1 SRX371482 | MCF-7 Breast | 474 / 18302 (2.6%) | 15905 / 183020 (8.7%) | −235.6 | −233.0 | 0.30 |
| FOS SRX150476 | MCF 10A Breast | 567 / 18302 (3.1%) | 17391 / 183020 (9.5%) | −234.5 | −231.9 | 0.33 |
| FOXA1 SRX371483 | MCF-7 Breast | 362 / 18302 (2.0%) | 13832 / 183020 (7.6%) | −230.8 | −228.2 | 0.26 |
| ING5 SRX286202 | RKO Digestive tract | 1525 / 18302 (8.3%) | 5522 / 183020 (3.0%) | −230.6 | −228.0 | 2.76 |
| TP53 SRX19538271 | U2OS Bone | 719 / 18302 (3.9%) | 1352 / 183020 (0.7%) | −229.4 | −226.8 | 5.32 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 745 / 18302 (4.1%) | 1466 / 183020 (0.8%) | −228.5 | −226.0 | 5.08 |
| ESR1 SRX7624156 | MCF-7 Breast | 544 / 18302 (3.0%) | 16747 / 183020 (9.2%) | −226.2 | −223.6 | 0.32 |
| TP53 SRX396254 | Fibroblasts Others | 1043 / 18302 (5.7%) | 2887 / 183020 (1.6%) | −226.1 | −223.6 | 3.61 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 382 / 18302 (2.1%) | 14034 / 183020 (7.7%) | −225.9 | −223.4 | 0.27 |
| FOXA1 SRX371481 | MCF-7 Breast | 347 / 18302 (1.9%) | 13412 / 183020 (7.3%) | −225.6 | −223.1 | 0.26 |
| ESR1 SRX4367193 | MCF-7 Breast | 1157 / 18302 (6.3%) | 25639 / 183020 (14.0%) | −221.1 | −218.5 | 0.45 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 393 / 18302 (2.1%) | 14068 / 183020 (7.7%) | −220.9 | −218.3 | 0.28 |
| FOXA1 SRX1161173 | MCF-7 Breast | 247 / 18302 (1.3%) | 11422 / 183020 (6.2%) | −220.5 | −217.9 | 0.22 |
| JUNB SRX8488088 | SUM 229PE Breast | 677 / 18302 (3.7%) | 18643 / 183020 (10.2%) | −220.4 | −217.9 | 0.36 |
| ESR1 SRX20282961 | MCF-7 Breast | 431 / 18302 (2.4%) | 14696 / 183020 (8.0%) | −220.2 | −217.7 | 0.29 |
| FOXA1 SRX1161176 | MCF-7 Breast | 313 / 18302 (1.7%) | 12633 / 183020 (6.9%) | −220.1 | −217.6 | 0.25 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 425 / 18302 (2.3%) | 14590 / 183020 (8.0%) | −220.1 | −217.6 | 0.29 |
| ESR1 SRX371469 | MCF-7 Breast | 347 / 18302 (1.9%) | 13237 / 183020 (7.2%) | −219.9 | −217.4 | 0.26 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 246 / 18302 (1.3%) | 11363 / 183020 (6.2%) | −219.2 | −216.7 | 0.22 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 304 / 18302 (1.7%) | 112 / 183020 (0.1%) | −218.3 | −215.7 | 27.14 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1928 / 18302 (10.5%) | 8285 / 183020 (4.5%) | −217.7 | −215.2 | 2.33 |
| ESR1 SRX176860 | MCF-7 Breast | 581 / 18302 (3.2%) | 16989 / 183020 (9.3%) | −215.7 | −213.2 | 0.34 |
| AR SRX1067071 | LHSAR Prostate | 700 / 18302 (3.8%) | 18793 / 183020 (10.3%) | −214.7 | −212.2 | 0.37 |
| TLE3 SRX4815191 | MCF-7 Breast | 320 / 18302 (1.7%) | 12540 / 183020 (6.9%) | −212.9 | −210.4 | 0.26 |
| FOXA1 SRX1161175 | MCF-7 Breast | 238 / 18302 (1.3%) | 11017 / 183020 (6.0%) | −212.6 | −210.1 | 0.22 |
| ESR1 SRX176861 | MCF-7 Breast | 587 / 18302 (3.2%) | 16960 / 183020 (9.3%) | −212.1 | −209.6 | 0.35 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 613 / 18302 (3.3%) | 17362 / 183020 (9.5%) | −212.1 | −209.6 | 0.35 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 789 / 18302 (4.3%) | 20031 / 183020 (10.9%) | −212.0 | −209.5 | 0.39 |
| FOXA1 SRX1787653 | MCF-7 Breast | 263 / 18302 (1.4%) | 11388 / 183020 (6.2%) | −209.3 | −206.8 | 0.23 |
| FOS SRX4192879 | MCF 10A Breast | 393 / 18302 (2.1%) | 13675 / 183020 (7.5%) | −208.5 | −206.1 | 0.29 |
| TRP47 SRX4548329 | THP-1 Blood | 2850 / 18302 (15.6%) | 15002 / 183020 (8.2%) | −208.3 | −205.9 | 1.90 |
| GATA3 SRX176864 | MCF-7 Breast | 235 / 18302 (1.3%) | 10829 / 183020 (5.9%) | −208.2 | −205.8 | 0.22 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 462 / 18302 (2.5%) | 14816 / 183020 (8.1%) | −208.1 | −205.7 | 0.31 |
| JADE3 DRX300415 | 293 Kidney | 1719 / 18302 (9.4%) | 7105 / 183020 (3.9%) | −207.8 | −205.4 | 2.42 |
| ESR1 SRX371471 | ZR-75-1 Breast | 379 / 18302 (2.1%) | 13409 / 183020 (7.3%) | −207.7 | −205.2 | 0.28 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 916 / 18302 (5.0%) | 2445 / 183020 (1.3%) | −206.8 | −204.3 | 3.75 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1275 / 18302 (7.0%) | 4394 / 183020 (2.4%) | −206.7 | −204.2 | 2.90 |
| SREBF2 SRX5359048 | HCC70 Breast | 1869 / 18302 (10.2%) | 8148 / 183020 (4.5%) | −204.5 | −202.1 | 2.29 |
| ESR1 SRX371476 | MCF-7 Breast | 248 / 18302 (1.4%) | 10920 / 183020 (6.0%) | −202.9 | −200.5 | 0.23 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 335 / 18302 (1.8%) | 12497 / 183020 (6.8%) | −202.9 | −200.4 | 0.27 |
| ESR1 SRX20282939 | MCF-7 Breast | 411 / 18302 (2.2%) | 13780 / 183020 (7.5%) | −202.3 | −199.9 | 0.30 |
| ESR1 SRX371479 | MCF-7 Breast | 325 / 18302 (1.8%) | 12294 / 183020 (6.7%) | −202.0 | −199.6 | 0.26 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 524 / 18302 (2.9%) | 15607 / 183020 (8.5%) | −201.6 | −199.2 | 0.34 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 719 / 18302 (3.9%) | 1559 / 183020 (0.9%) | −201.5 | −199.1 | 4.61 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 536 / 18302 (2.9%) | 15783 / 183020 (8.6%) | −201.2 | −198.8 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 1267 / 18302 (6.9%) | 4431 / 183020 (2.4%) | −200.9 | −198.5 | 2.86 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1507 / 18302 (8.2%) | 5887 / 183020 (3.2%) | −200.5 | −198.1 | 2.56 |
| FOXA1 SRX371480 | MCF-7 Breast | 227 / 18302 (1.2%) | 10439 / 183020 (5.7%) | −200.1 | −197.7 | 0.22 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 583 / 18302 (3.2%) | 1002 / 183020 (0.5%) | −200.0 | −197.6 | 5.82 |
| AR SRX10820651 | LNCAP Prostate | 384 / 18302 (2.1%) | 339 / 183020 (0.2%) | −199.7 | −197.3 | 11.33 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1349 / 18302 (7.4%) | 27366 / 183020 (15.0%) | −199.1 | −196.7 | 0.49 |
| ESR1 SRX371470 | ZR-75-1 Breast | 323 / 18302 (1.8%) | 12161 / 183020 (6.6%) | −199.0 | −196.6 | 0.27 |
| ARID1A SRX5089376 | MCF-7 Breast | 300 / 18302 (1.6%) | 11722 / 183020 (6.4%) | −198.0 | −195.6 | 0.26 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 312 / 18302 (1.7%) | 11928 / 183020 (6.5%) | −197.8 | −195.4 | 0.26 |
| GATA3 SRX5057632 | MCF-7 Breast | 216 / 18302 (1.2%) | 10159 / 183020 (5.6%) | −197.7 | −195.3 | 0.21 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1461 / 18302 (8.0%) | 28727 / 183020 (15.7%) | −196.3 | −193.9 | 0.51 |
| LEO1 SRX1873456 | SEM Blood | 1601 / 18302 (8.7%) | 6562 / 183020 (3.6%) | −195.8 | −193.4 | 2.44 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1722 / 18302 (9.4%) | 7362 / 183020 (4.0%) | −195.0 | −192.6 | 2.34 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1566 / 18302 (8.6%) | 6366 / 183020 (3.5%) | −194.2 | −191.9 | 2.46 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 915 / 18302 (5.0%) | 2575 / 183020 (1.4%) | −193.9 | −191.5 | 3.55 |
| ESR1 SRX20282960 | MCF-7 Breast | 429 / 18302 (2.3%) | 13805 / 183020 (7.5%) | −193.9 | −191.5 | 0.31 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 330 / 18302 (1.8%) | 12116 / 183020 (6.6%) | −193.6 | −191.3 | 0.27 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 647 / 18302 (3.5%) | 17240 / 183020 (9.4%) | −193.6 | −191.3 | 0.38 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1899 / 18302 (10.4%) | 8577 / 183020 (4.7%) | −193.4 | −191.0 | 2.21 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 325 / 18302 (1.8%) | 12011 / 183020 (6.6%) | −193.0 | −190.6 | 0.27 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 390 / 18302 (2.1%) | 13118 / 183020 (7.2%) | −192.8 | −190.4 | 0.30 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 327 / 18302 (1.8%) | 12021 / 183020 (6.6%) | −192.1 | −189.8 | 0.27 |
| ESR1 SRX194572 | MCF-7 Breast | 221 / 18302 (1.2%) | 10086 / 183020 (5.5%) | −192.0 | −189.7 | 0.22 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2090 / 18302 (11.4%) | 9935 / 183020 (5.4%) | −191.3 | −188.9 | 2.10 |
| ESR1 SRX371468 | MCF-7 Breast | 225 / 18302 (1.2%) | 10130 / 183020 (5.5%) | −191.0 | −188.7 | 0.22 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 983 / 18302 (5.4%) | 2967 / 183020 (1.6%) | −190.9 | −188.6 | 3.31 |
| RAC1 SRX10365541 | MCF-7 Breast | 178 / 18302 (1.0%) | 9196 / 183020 (5.0%) | −190.4 | −188.1 | 0.19 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 624 / 18302 (3.4%) | 16767 / 183020 (9.2%) | −190.1 | −187.8 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 384 / 18302 (2.1%) | 12904 / 183020 (7.1%) | −189.2 | −186.9 | 0.30 |
| RAC1 SRX10365543 | MCF-7 Breast | 175 / 18302 (1.0%) | 9104 / 183020 (5.0%) | −189.2 | −186.8 | 0.19 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1294 / 18302 (7.1%) | 26201 / 183020 (14.3%) | −188.8 | −186.5 | 0.49 |
| FOXA1 SRX11222441 | MCF-7 Breast | 274 / 18302 (1.5%) | 10962 / 183020 (6.0%) | −188.4 | −186.1 | 0.25 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 489 / 18302 (2.7%) | 14590 / 183020 (8.0%) | −188.2 | −185.9 | 0.34 |
| AR SRX1067070 | LHSAR Prostate | 944 / 18302 (5.2%) | 21360 / 183020 (11.7%) | −187.8 | −185.5 | 0.44 |
| ESR1 SRX1531791 | MCF-7 Breast | 365 / 18302 (2.0%) | 12524 / 183020 (6.8%) | −187.5 | −185.2 | 0.29 |
| FOXA1 SRX3923514 | MCF-7 Breast | 382 / 18302 (2.1%) | 12803 / 183020 (7.0%) | −187.3 | −185.0 | 0.30 |
| ESR1 SRX194569 | MCF-7 Breast | 397 / 18302 (2.2%) | 13052 / 183020 (7.1%) | −187.2 | −184.9 | 0.30 |
| FOXA2 SRX3230382 | Hep G2 Liver | 516 / 18302 (2.8%) | 14981 / 183020 (8.2%) | −187.1 | −184.8 | 0.34 |
| AR SRX1067067 | LHSAR Prostate | 649 / 18302 (3.5%) | 17032 / 183020 (9.3%) | −187.0 | −184.7 | 0.38 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 284 / 18302 (1.6%) | 11097 / 183020 (6.1%) | −186.9 | −184.6 | 0.26 |
| KAT7 DRX234808 | 293 Kidney | 875 / 18302 (4.8%) | 2452 / 183020 (1.3%) | −186.3 | −184.0 | 3.57 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2047 / 18302 (11.2%) | 9754 / 183020 (5.3%) | −186.1 | −183.9 | 2.10 |
| BMI1 SRX644729 | 293 Kidney | 280 / 18302 (1.5%) | 134 / 183020 (0.1%) | −186.1 | −183.8 | 20.90 |
| ESR1 SRX371467 | MCF-7 Breast | 403 / 18302 (2.2%) | 13097 / 183020 (7.2%) | −185.5 | −183.2 | 0.31 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1951 / 18302 (10.7%) | 9102 / 183020 (5.0%) | −185.4 | −183.1 | 2.14 |
| FOXA1 SRX11222437 | MCF-7 Breast | 259 / 18302 (1.4%) | 10584 / 183020 (5.8%) | −185.1 | −182.8 | 0.24 |
| ESR1 SRX20282972 | MCF-7 Breast | 427 / 18302 (2.3%) | 13478 / 183020 (7.4%) | −185.0 | −182.7 | 0.32 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 374 / 18302 (2.0%) | 12590 / 183020 (6.9%) | −184.8 | −182.5 | 0.30 |
| MECOM SRX23677885 | HNT-34 Blood | 1896 / 18302 (10.4%) | 8756 / 183020 (4.8%) | −184.0 | −181.7 | 2.17 |
| STAT5B SRX831881 | CD8+ T cells Blood | 285 / 18302 (1.6%) | 149 / 183020 (0.1%) | −183.9 | −181.6 | 19.13 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 353 / 18302 (1.9%) | 12203 / 183020 (6.7%) | −183.8 | −181.6 | 0.29 |
| ESR1 SRX20282954 | MCF-7 Breast | 420 / 18302 (2.3%) | 13319 / 183020 (7.3%) | −183.7 | −181.5 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 211 / 18302 (1.2%) | 9637 / 183020 (5.3%) | −183.4 | −181.1 | 0.22 |
| MITF SRX1555436 | 501A Epidermis | 2093 / 18302 (11.4%) | 10145 / 183020 (5.5%) | −183.2 | −180.9 | 2.06 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 851 / 18302 (4.6%) | 2366 / 183020 (1.3%) | −182.8 | −180.5 | 3.60 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 748 / 18302 (4.1%) | 1856 / 183020 (1.0%) | −182.7 | −180.5 | 4.03 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1751 / 18302 (9.6%) | 7801 / 183020 (4.3%) | −182.6 | −180.4 | 2.24 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 358 / 18302 (2.0%) | 12241 / 183020 (6.7%) | −182.4 | −180.1 | 0.29 |
| ESR1 SRX2943591 | MCF-7 Breast | 252 / 18302 (1.4%) | 10369 / 183020 (5.7%) | −182.2 | −180.0 | 0.24 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 254 / 18302 (1.4%) | 10388 / 183020 (5.7%) | −181.7 | −179.4 | 0.24 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 342 / 18302 (1.9%) | 11940 / 183020 (6.5%) | −181.5 | −179.2 | 0.29 |
| ARID1A SRX5089379 | MCF-7 Breast | 380 / 18302 (2.1%) | 12580 / 183020 (6.9%) | −181.5 | −179.2 | 0.30 |
| FOXA1 SRX100506 | Hep G2 Liver | 513 / 18302 (2.8%) | 14737 / 183020 (8.1%) | −181.4 | −179.2 | 0.35 |
| FOXA1 SRX100454 | T-47D Breast | 507 / 18302 (2.8%) | 14585 / 183020 (8.0%) | −179.8 | −177.5 | 0.35 |
| FOXA1 SRX3931043 | MCF-7 Breast | 391 / 18302 (2.1%) | 12707 / 183020 (6.9%) | −179.6 | −177.4 | 0.31 |
| ESR1 SRX10365536 | MCF-7 Breast | 190 / 18302 (1.0%) | 9119 / 183020 (5.0%) | −179.6 | −177.3 | 0.21 |
| CXXC1 SRX1424886 | SEM Blood | 1571 / 18302 (8.6%) | 6673 / 183020 (3.6%) | −179.5 | −177.2 | 2.35 |
| JUN SRX4192884 | MCF 10A Breast | 311 / 18302 (1.7%) | 11333 / 183020 (6.2%) | −179.2 | −177.0 | 0.27 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 296 / 18302 (1.6%) | 11061 / 183020 (6.0%) | −179.1 | −176.8 | 0.27 |
| MECOM SRX23677884 | HNT-34 Blood | 1851 / 18302 (10.1%) | 8571 / 183020 (4.7%) | −178.3 | −176.1 | 2.16 |
| CEBPB SRX150632 | HeLa Uterus | 893 / 18302 (4.9%) | 20265 / 183020 (11.1%) | −178.3 | −176.1 | 0.44 |
| BMI1 SRX7196721 | SF8628 Neural | 1825 / 18302 (10.0%) | 8395 / 183020 (4.6%) | −178.2 | −176.0 | 2.17 |
| JUNB SRX8488089 | SUM 229PE Breast | 387 / 18302 (2.1%) | 12572 / 183020 (6.9%) | −177.6 | −175.4 | 0.31 |
| MECOM SRX23677896 | HNT-34 Blood | 2266 / 18302 (12.4%) | 11520 / 183020 (6.3%) | −177.5 | −175.3 | 1.97 |
| TLE3 SRX4815192 | MCF-7 Breast | 346 / 18302 (1.9%) | 11876 / 183020 (6.5%) | −177.5 | −175.2 | 0.29 |
| AR SRX9469988 | LAPC-4 Prostate | 516 / 18302 (2.8%) | 14648 / 183020 (8.0%) | −177.4 | −175.2 | 0.35 |
| AR SRX1067066 | LHSAR Prostate | 839 / 18302 (4.6%) | 19459 / 183020 (10.6%) | −177.3 | −175.1 | 0.43 |
| FOXA1 SRX3931055 | MCF-7 Breast | 324 / 18302 (1.8%) | 11479 / 183020 (6.3%) | −176.8 | −174.6 | 0.28 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 166 / 18302 (0.9%) | 8564 / 183020 (4.7%) | −176.8 | −174.6 | 0.19 |
| STAT1 SRX23678708 | K-562 Blood | 1644 / 18302 (9.0%) | 7215 / 183020 (3.9%) | −176.3 | −174.1 | 2.28 |
| FOXA1 SRX11222442 | MCF-7 Breast | 251 / 18302 (1.4%) | 10138 / 183020 (5.5%) | −175.3 | −173.1 | 0.25 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1699 / 18302 (9.3%) | 7609 / 183020 (4.2%) | −175.0 | −172.8 | 2.23 |
| ESR1 SRX371477 | MCF-7 Breast | 178 / 18302 (1.0%) | 8727 / 183020 (4.8%) | −174.2 | −172.0 | 0.20 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1328 / 18302 (7.3%) | 26008 / 183020 (14.2%) | −173.8 | −171.7 | 0.51 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 342 / 18302 (1.9%) | 11684 / 183020 (6.4%) | −173.6 | −171.4 | 0.29 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 363 / 18302 (2.0%) | 12020 / 183020 (6.6%) | −173.1 | −170.9 | 0.30 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 972 / 18302 (5.3%) | 21151 / 183020 (11.6%) | −172.7 | −170.5 | 0.46 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 962 / 18302 (5.3%) | 21009 / 183020 (11.5%) | −172.7 | −170.5 | 0.46 |
| FOXA2 SRX100448 | Hep G2 Liver | 438 / 18302 (2.4%) | 13227 / 183020 (7.2%) | −172.3 | −170.1 | 0.33 |
| JUN SRX17561461 | LPS141 Adipocyte | 585 / 18302 (3.2%) | 15525 / 183020 (8.5%) | −172.2 | −170.0 | 0.38 |
| FOXA1 SRX1787651 | MCF-7 Breast | 207 / 18302 (1.1%) | 9211 / 183020 (5.0%) | −171.7 | −169.5 | 0.22 |
| FOXA1 SRX3931054 | MCF-7 Breast | 373 / 18302 (2.0%) | 12138 / 183020 (6.6%) | −171.6 | −169.4 | 0.31 |
| FOXA1 SRX5323843 | MCF-7 Breast | 190 / 18302 (1.0%) | 8878 / 183020 (4.9%) | −171.4 | −169.2 | 0.21 |
| MECOM SRX23677897 | HNT-34 Blood | 2170 / 18302 (11.9%) | 10987 / 183020 (6.0%) | −171.2 | −169.0 | 1.98 |
| ESR1 SRX371475 | BT-474 Breast | 186 / 18302 (1.0%) | 8796 / 183020 (4.8%) | −171.2 | −169.0 | 0.21 |
| CDK9 SRX7366783 | MCF-7 Breast | 269 / 18302 (1.5%) | 148 / 183020 (0.1%) | −170.5 | −168.4 | 18.18 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1921 / 18302 (10.5%) | 9233 / 183020 (5.0%) | −170.5 | −168.3 | 2.08 |
| JUNB SRX10119386 | MCF 10A Breast | 358 / 18302 (2.0%) | 11849 / 183020 (6.5%) | −170.4 | −168.2 | 0.30 |
| ZFX SRX7805372 | 293 Kidney | 1652 / 18302 (9.0%) | 7394 / 183020 (4.0%) | −170.1 | −168.0 | 2.23 |
| GATA3 SRX6712581 | MCF-7 Breast | 324 / 18302 (1.8%) | 11258 / 183020 (6.2%) | −169.9 | −167.7 | 0.29 |
| RUNX1 SRX2014504 | Jurkat Blood | 2551 / 18302 (13.9%) | 13836 / 183020 (7.6%) | −169.7 | −167.6 | 1.84 |
| FOS SRX3322636 | MCF-7 Breast | 239 / 18302 (1.3%) | 9744 / 183020 (5.3%) | −169.5 | −167.3 | 0.25 |
| GATA3 SRX5457550 | MCF-7 Breast | 454 / 18302 (2.5%) | 13386 / 183020 (7.3%) | −169.4 | −167.3 | 0.34 |
| TP53 SRX19538272 | U2OS Bone | 592 / 18302 (3.2%) | 1255 / 183020 (0.7%) | −169.3 | −167.1 | 4.72 |
| PGR SRX1012655 | MCF-7 Breast | 241 / 18302 (1.3%) | 9753 / 183020 (5.3%) | −168.6 | −166.5 | 0.25 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 521 / 18302 (2.8%) | 14413 / 183020 (7.9%) | −168.6 | −166.4 | 0.36 |
| FOXA1 SRX028634 | MCF-7 Breast | 184 / 18302 (1.0%) | 8676 / 183020 (4.7%) | −168.4 | −166.3 | 0.21 |
| Epitope tags SRX10549777 | K-562 Blood | 2588 / 18302 (14.1%) | 14157 / 183020 (7.7%) | −168.2 | −166.1 | 1.83 |
| JUNB SRX8488073 | SUM 229PE Breast | 771 / 18302 (4.2%) | 18129 / 183020 (9.9%) | −168.2 | −166.1 | 0.43 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 794 / 18302 (4.3%) | 18460 / 183020 (10.1%) | −168.1 | −166.0 | 0.43 |
| FOXA1 SRX1787655 | MCF-7 Breast | 186 / 18302 (1.0%) | 8705 / 183020 (4.8%) | −168.1 | −165.9 | 0.21 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 366 / 18302 (2.0%) | 11906 / 183020 (6.5%) | −168.1 | −165.9 | 0.31 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 951 / 18302 (5.2%) | 20669 / 183020 (11.3%) | −168.0 | −165.9 | 0.46 |
| FOXA1 SRX3923517 | MCF-7 Breast | 275 / 18302 (1.5%) | 10332 / 183020 (5.6%) | −167.7 | −165.5 | 0.27 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1883 / 18302 (10.3%) | 9042 / 183020 (4.9%) | −167.3 | −165.1 | 2.08 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 436 / 18302 (2.4%) | 13025 / 183020 (7.1%) | −167.2 | −165.1 | 0.33 |
| JUNB SRX4192882 | MCF 10A Breast | 314 / 18302 (1.7%) | 10994 / 183020 (6.0%) | −167.1 | −165.0 | 0.29 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1317 / 18302 (7.2%) | 5270 / 183020 (2.9%) | −167.1 | −164.9 | 2.50 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 787 / 18302 (4.3%) | 18310 / 183020 (10.0%) | −166.9 | −164.8 | 0.43 |
| MEN1 SRX11712604 | K-562 Blood | 1500 / 18302 (8.2%) | 6450 / 183020 (3.5%) | −166.9 | −164.8 | 2.33 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 865 / 18302 (4.7%) | 19403 / 183020 (10.6%) | −166.5 | −164.4 | 0.45 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 281 / 18302 (1.5%) | 10402 / 183020 (5.7%) | −166.5 | −164.4 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 171 / 18302 (0.9%) | 8361 / 183020 (4.6%) | −166.4 | −164.3 | 0.20 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 786 / 18302 (4.3%) | 2226 / 183020 (1.2%) | −164.9 | −162.8 | 3.53 |
| FOXA1 SRX028635 | MCF-7 Breast | 187 / 18302 (1.0%) | 8625 / 183020 (4.7%) | −164.8 | −162.7 | 0.22 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1643 / 18302 (9.0%) | 7446 / 183020 (4.1%) | −164.8 | −162.7 | 2.21 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 425 / 18302 (2.3%) | 12761 / 183020 (7.0%) | −164.7 | −162.6 | 0.33 |
| SMARCA4 SRX5212366 | Mel270 Others | 555 / 18302 (3.0%) | 14797 / 183020 (8.1%) | −164.7 | −162.6 | 0.38 |
| ESR1 SRX20282946 | MCF-7 Breast | 235 / 18302 (1.3%) | 9522 / 183020 (5.2%) | −164.7 | −162.6 | 0.25 |
| STAT3 SRX2020842 | HCC70 Breast | 729 / 18302 (4.0%) | 17385 / 183020 (9.5%) | −164.7 | −162.6 | 0.42 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 368 / 18302 (2.0%) | 11815 / 183020 (6.5%) | −164.4 | −162.3 | 0.31 |
| SMARCA4 SRX5212362 | Mel270 Others | 714 / 18302 (3.9%) | 17134 / 183020 (9.4%) | −163.8 | −161.7 | 0.42 |
| FOXA1 SRX3923516 | MCF-7 Breast | 289 / 18302 (1.6%) | 10450 / 183020 (5.7%) | −163.6 | −161.5 | 0.28 |
| NFYB SRX16608147 | HeLa Uterus | 285 / 18302 (1.6%) | 203 / 183020 (0.1%) | −163.5 | −161.4 | 14.04 |
| ESR1 SRX10365532 | MCF-7 Breast | 212 / 18302 (1.2%) | 9054 / 183020 (4.9%) | −163.2 | −161.1 | 0.23 |
| SMARCA4 SRX5212357 | Mel270 Others | 601 / 18302 (3.3%) | 15426 / 183020 (8.4%) | −162.8 | −160.7 | 0.39 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1867 / 18302 (10.2%) | 9032 / 183020 (4.9%) | −162.8 | −160.7 | 2.07 |
| FOXA1 SRX1447317 | MCF-7 Breast | 257 / 18302 (1.4%) | 9854 / 183020 (5.4%) | −162.6 | −160.5 | 0.26 |
| YAP1 SRX5718140 | 293 Kidney | 711 / 18302 (3.9%) | 17031 / 183020 (9.3%) | −162.3 | −160.2 | 0.42 |
| ESR1 SRX4451213 | MCF-7 Breast | 418 / 18302 (2.3%) | 12567 / 183020 (6.9%) | −162.3 | −160.2 | 0.33 |
| EP300 SRX176885 | MCF-7 Breast | 201 / 18302 (1.1%) | 8813 / 183020 (4.8%) | −162.2 | −160.1 | 0.23 |
| JADE3 DRX234809 | 293 Kidney | 1086 / 18302 (5.9%) | 3938 / 183020 (2.2%) | −162.0 | −159.9 | 2.76 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1684 / 18302 (9.2%) | 7784 / 183020 (4.3%) | −161.9 | −159.9 | 2.16 |
| KAT7 DRX300414 | 293 Kidney | 674 / 18302 (3.7%) | 1702 / 183020 (0.9%) | −161.4 | −159.3 | 3.96 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 188 / 18302 (1.0%) | 8543 / 183020 (4.7%) | −161.3 | −159.2 | 0.22 |
| FOXA1 SRX11222438 | MCF-7 Breast | 214 / 18302 (1.2%) | 9025 / 183020 (4.9%) | −161.1 | −159.0 | 0.24 |
| ESR1 SRX330067 | MCF-7 Breast | 370 / 18302 (2.0%) | 11735 / 183020 (6.4%) | −161.0 | −158.9 | 0.32 |
| ARID1A SRX5089385 | MCF-7 Breast | 305 / 18302 (1.7%) | 10638 / 183020 (5.8%) | −160.8 | −158.7 | 0.29 |
| ESR1 SRX2881002 | MCF-7 Breast | 392 / 18302 (2.1%) | 12084 / 183020 (6.6%) | −160.6 | −158.5 | 0.32 |
| SMARCA2 SRX8119677 | MeT-5A Others | 683 / 18302 (3.7%) | 16555 / 183020 (9.0%) | −160.5 | −158.4 | 0.41 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 575 / 18302 (3.1%) | 1250 / 183020 (0.7%) | −160.5 | −158.4 | 4.60 |
| GATA3 SRX190194 | SK-N-SH Neural | 984 / 18302 (5.4%) | 20813 / 183020 (11.4%) | −160.4 | −158.3 | 0.47 |
| ESR1 SRX4367192 | MCF-7 Breast | 856 / 18302 (4.7%) | 19029 / 183020 (10.4%) | −160.4 | −158.3 | 0.45 |
| ESR1 SRX2943589 | MCF-7 Breast | 199 / 18302 (1.1%) | 8721 / 183020 (4.8%) | −160.4 | −158.3 | 0.23 |
| ESR1 SRX10365535 | MCF-7 Breast | 338 / 18302 (1.8%) | 11182 / 183020 (6.1%) | −160.3 | −158.3 | 0.30 |
| NR2F2 SRX190293 | MCF-7 Breast | 441 / 18302 (2.4%) | 12862 / 183020 (7.0%) | −160.3 | −158.2 | 0.34 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1298 / 18302 (7.1%) | 5270 / 183020 (2.9%) | −160.2 | −158.2 | 2.46 |
| FOXA1 SRX3923518 | MCF-7 Breast | 280 / 18302 (1.5%) | 10180 / 183020 (5.6%) | −160.1 | −158.1 | 0.28 |
| ESR1 SRX20282955 | MCF-7 Breast | 444 / 18302 (2.4%) | 12905 / 183020 (7.1%) | −160.1 | −158.1 | 0.34 |
| SSRP1 SRX3436567 | HT-1080 Bone | 418 / 18302 (2.3%) | 620 / 183020 (0.3%) | −160.0 | −157.9 | 6.74 |
| FOXA1 SRX6878603 | LNCAP Prostate | 461 / 18302 (2.5%) | 13165 / 183020 (7.2%) | −159.9 | −157.9 | 0.35 |
| FOXA1 SRX15430999 | T-47D Breast | 460 / 18302 (2.5%) | 13152 / 183020 (7.2%) | −159.9 | −157.9 | 0.35 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1317 / 18302 (7.2%) | 25248 / 183020 (13.8%) | −159.9 | −157.8 | 0.52 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 323 / 18302 (1.8%) | 10904 / 183020 (6.0%) | −159.6 | −157.6 | 0.30 |
| ESR1 SRX20282973 | MCF-7 Breast | 514 / 18302 (2.8%) | 13973 / 183020 (7.6%) | −159.4 | −157.3 | 0.37 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 402 / 18302 (2.2%) | 12207 / 183020 (6.7%) | −159.4 | −157.3 | 0.33 |
| FOXA1 SRX3931033 | MCF-7 Breast | 258 / 18302 (1.4%) | 9768 / 183020 (5.3%) | −159.3 | −157.3 | 0.26 |
| ESR1 SRX20282940 | MCF-7 Breast | 460 / 18302 (2.5%) | 13117 / 183020 (7.2%) | −159.0 | −156.9 | 0.35 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1601 / 18302 (8.7%) | 7284 / 183020 (4.0%) | −158.9 | −156.9 | 2.20 |
| STAT1 SRX23678707 | K-562 Blood | 1504 / 18302 (8.2%) | 6635 / 183020 (3.6%) | −158.9 | −156.8 | 2.27 |
| EP300 SRX1012648 | MCF-7 Breast | 185 / 18302 (1.0%) | 8408 / 183020 (4.6%) | −158.7 | −156.7 | 0.22 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 821 / 18302 (4.5%) | 18466 / 183020 (10.1%) | −158.6 | −156.5 | 0.44 |
| CEBPA SRX2630241 | Hep G2 Liver | 509 / 18302 (2.8%) | 13870 / 183020 (7.6%) | −158.6 | −156.5 | 0.37 |
| NKX2-1 SRX2164786 | A549 Lung | 699 / 18302 (3.8%) | 16702 / 183020 (9.1%) | −158.3 | −156.2 | 0.42 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1140 / 18302 (6.2%) | 4325 / 183020 (2.4%) | −158.0 | −155.9 | 2.64 |
| ESR1 SRX2881000 | MCF-7 Breast | 371 / 18302 (2.0%) | 11646 / 183020 (6.4%) | −157.8 | −155.7 | 0.32 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1102 / 18302 (6.0%) | 22300 / 183020 (12.2%) | −157.7 | −155.6 | 0.49 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 361 / 18302 (2.0%) | 11467 / 183020 (6.3%) | −157.4 | −155.4 | 0.31 |
| ARID1A SRX5089391 | MCF-7 Breast | 225 / 18302 (1.2%) | 9111 / 183020 (5.0%) | −157.4 | −155.3 | 0.25 |
| TEAD1 SRX3401272 | MCF-7 Breast | 321 / 18302 (1.8%) | 10797 / 183020 (5.9%) | −157.3 | −155.3 | 0.30 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 598 / 18302 (3.3%) | 15168 / 183020 (8.3%) | −157.1 | −155.1 | 0.39 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 312 / 18302 (1.7%) | 10632 / 183020 (5.8%) | −157.0 | −155.0 | 0.29 |
| FOXA1 SRX3931056 | MCF-7 Breast | 238 / 18302 (1.3%) | 9338 / 183020 (5.1%) | −156.9 | −154.9 | 0.25 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2142 / 18302 (11.7%) | 11167 / 183020 (6.1%) | −156.4 | −154.4 | 1.92 |
| FOXA1 SRX100477 | Hep G2 Liver | 484 / 18302 (2.6%) | 13400 / 183020 (7.3%) | −156.3 | −154.3 | 0.36 |
| KMT2A SRX2323891 | 293 Kidney | 1020 / 18302 (5.6%) | 3632 / 183020 (2.0%) | −156.3 | −154.3 | 2.81 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 600 / 18302 (3.3%) | 15162 / 183020 (8.3%) | −156.1 | −154.1 | 0.40 |
| ESR1 SRX3110725 | MCF-7 Breast | 377 / 18302 (2.1%) | 11672 / 183020 (6.4%) | −155.7 | −153.7 | 0.32 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 918 / 18302 (5.0%) | 3055 / 183020 (1.7%) | −155.6 | −153.5 | 3.00 |
| EP300 SRX150579 | HeLa Uterus | 273 / 18302 (1.5%) | 9914 / 183020 (5.4%) | −155.5 | −153.5 | 0.28 |
| ESR1 SRX10365533 | MCF-7 Breast | 189 / 18302 (1.0%) | 8375 / 183020 (4.6%) | −155.2 | −153.2 | 0.23 |
| STAT3 SRX150479 | MCF 10A Breast | 390 / 18302 (2.1%) | 11867 / 183020 (6.5%) | −155.1 | −153.1 | 0.33 |
| CDK9 SRX7366781 | MCF-7 Breast | 249 / 18302 (1.4%) | 144 / 183020 (0.1%) | −155.1 | −153.1 | 17.29 |
| FOXA1 SRX5203303 | MCF-7 Breast | 131 / 18302 (0.7%) | 7227 / 183020 (3.9%) | −155.0 | −153.0 | 0.18 |
| ESR1 SRX330069 | MCF-7 Breast | 253 / 18302 (1.4%) | 9540 / 183020 (5.2%) | −154.9 | −152.9 | 0.27 |
| STAT3 SRX150536 | MCF 10A Breast | 468 / 18302 (2.6%) | 13094 / 183020 (7.2%) | −154.7 | −152.7 | 0.36 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1948 / 18302 (10.6%) | 9807 / 183020 (5.4%) | −154.6 | −152.6 | 1.99 |
| ESR1 SRX1012632 | MCF-7 Breast | 199 / 18302 (1.1%) | 8542 / 183020 (4.7%) | −154.5 | −152.5 | 0.23 |
| ARID5B SRX3230377 | Hep G2 Liver | 1062 / 18302 (5.8%) | 21620 / 183020 (11.8%) | −154.4 | −152.4 | 0.49 |
| NR3C1 SRX19024866 | MCF-7 Breast | 132 / 18302 (0.7%) | 7226 / 183020 (3.9%) | −154.3 | −152.3 | 0.18 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 399 / 18302 (2.2%) | 11971 / 183020 (6.5%) | −153.9 | −151.9 | 0.33 |
| GATAD2A SRX2636506 | Hep G2 Liver | 547 / 18302 (3.0%) | 14270 / 183020 (7.8%) | −153.7 | −151.7 | 0.38 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 268 / 18302 (1.5%) | 9765 / 183020 (5.3%) | −153.6 | −151.6 | 0.27 |
| EP300 ERX626821 | U-937 Blood | 1276 / 18302 (7.0%) | 5256 / 183020 (2.9%) | −153.2 | −151.2 | 2.43 |
| SOX13 SRX2636248 | Hep G2 Liver | 589 / 18302 (3.2%) | 14883 / 183020 (8.1%) | −153.2 | −151.2 | 0.40 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 628 / 18302 (3.4%) | 15464 / 183020 (8.4%) | −153.1 | −151.1 | 0.41 |
| ESR1 SRX1012629 | MCF-7 Breast | 262 / 18302 (1.4%) | 9627 / 183020 (5.3%) | −152.6 | −150.6 | 0.27 |
| ESR1 SRX1531796 | MCF-7 Breast | 219 / 18302 (1.2%) | 8854 / 183020 (4.8%) | −152.6 | −150.6 | 0.25 |
| PROX1 SRX3230397 | Hep G2 Liver | 309 / 18302 (1.7%) | 10439 / 183020 (5.7%) | −152.6 | −150.6 | 0.30 |
| ESR1 SRX330070 | MCF-7 Breast | 213 / 18302 (1.2%) | 8743 / 183020 (4.8%) | −152.5 | −150.6 | 0.24 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 346 / 18302 (1.9%) | 11053 / 183020 (6.0%) | −152.4 | −150.4 | 0.31 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1257 / 18302 (6.9%) | 24126 / 183020 (13.2%) | −152.4 | −150.4 | 0.52 |
| JUND SRX150408 | HeLa Uterus | 373 / 18302 (2.0%) | 11492 / 183020 (6.3%) | −152.4 | −150.4 | 0.32 |
| STAT3 SRX150630 | MCF 10A Breast | 393 / 18302 (2.1%) | 11815 / 183020 (6.5%) | −152.2 | −150.2 | 0.33 |
| NR3C1 SRX17639412 | A549 Lung | 482 / 18302 (2.6%) | 13216 / 183020 (7.2%) | −152.1 | −150.1 | 0.36 |
| FOXA1 SRX1787654 | MCF-7 Breast | 146 / 18302 (0.8%) | 7449 / 183020 (4.1%) | −152.0 | −150.1 | 0.20 |
| ARID1A SRX5089382 | MCF-7 Breast | 302 / 18302 (1.7%) | 10295 / 183020 (5.6%) | −151.8 | −149.8 | 0.29 |
| ZFX SRX7805370 | 293 Kidney | 1184 / 18302 (6.5%) | 4708 / 183020 (2.6%) | −151.4 | −149.4 | 2.51 |
| ZEB1 SRX13298925 | MCF-7 Breast | 262 / 18302 (1.4%) | 9577 / 183020 (5.2%) | −151.0 | −149.0 | 0.27 |
| AR SRX9109110 | MDA-MB-453 Breast | 806 / 18302 (4.4%) | 17945 / 183020 (9.8%) | −151.0 | −149.0 | 0.45 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 143 / 18302 (0.8%) | 7353 / 183020 (4.0%) | −150.9 | −148.9 | 0.19 |
| FOXA1 SRX3923519 | MCF-7 Breast | 260 / 18302 (1.4%) | 9536 / 183020 (5.2%) | −150.8 | −148.8 | 0.27 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 363 / 18302 (2.0%) | 11276 / 183020 (6.2%) | −150.7 | −148.7 | 0.32 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1218 / 18302 (6.7%) | 23532 / 183020 (12.9%) | −150.6 | −148.6 | 0.52 |
| FOXA1 SRX9604647 | LNCAP Prostate | 660 / 18302 (3.6%) | 15838 / 183020 (8.7%) | −150.6 | −148.6 | 0.42 |
| TET2 SRX1427029 | 293 Kidney | 1335 / 18302 (7.3%) | 5698 / 183020 (3.1%) | −150.0 | −148.0 | 2.34 |
| HMG20A SRX2630163 | Hep G2 Liver | 237 / 18302 (1.3%) | 9094 / 183020 (5.0%) | −149.8 | −147.9 | 0.26 |
| FOSL2 SRX190204 | A549 Lung | 428 / 18302 (2.3%) | 12287 / 183020 (6.7%) | −149.7 | −147.7 | 0.35 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 411 / 18302 (2.2%) | 12005 / 183020 (6.6%) | −149.4 | −147.4 | 0.34 |
| ESR1 SRX8537722 | MCF-7 Breast | 406 / 18302 (2.2%) | 11917 / 183020 (6.5%) | −149.1 | −147.2 | 0.34 |
| EP300 SRX1012643 | MCF-7 Breast | 144 / 18302 (0.8%) | 7319 / 183020 (4.0%) | −149.0 | −147.1 | 0.20 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 456 / 18302 (2.5%) | 12690 / 183020 (6.9%) | −148.7 | −146.8 | 0.36 |
| ARID1A SRX5089388 | MCF-7 Breast | 218 / 18302 (1.2%) | 8717 / 183020 (4.8%) | −148.6 | −146.7 | 0.25 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 410 / 18302 (2.2%) | 11954 / 183020 (6.5%) | −148.4 | −146.5 | 0.34 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 757 / 18302 (4.1%) | 17142 / 183020 (9.4%) | −148.3 | −146.3 | 0.44 |
| FOXA1 SRX1961158 | T-47D Breast | 430 / 18302 (2.3%) | 12264 / 183020 (6.7%) | −148.2 | −146.2 | 0.35 |
| TCF12 SRX190356 | SK-N-SH Neural | 1164 / 18302 (6.4%) | 22709 / 183020 (12.4%) | −148.1 | −146.1 | 0.51 |
| FOXA1 SRX1961157 | T-47D Breast | 474 / 18302 (2.6%) | 12946 / 183020 (7.1%) | −148.0 | −146.0 | 0.37 |
| FOXA1 SRX3931032 | MCF-7 Breast | 250 / 18302 (1.4%) | 9266 / 183020 (5.1%) | −148.0 | −146.0 | 0.27 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 519 / 18302 (2.8%) | 13637 / 183020 (7.5%) | −147.9 | −146.0 | 0.38 |
| FOXA1 SRX5323829 | T-47D Breast | 238 / 18302 (1.3%) | 9053 / 183020 (4.9%) | −147.9 | −145.9 | 0.26 |
| JUNB SRX8488074 | SUM 229PE Breast | 586 / 18302 (3.2%) | 14636 / 183020 (8.0%) | −147.8 | −145.8 | 0.40 |
| FOXA1 SRX5203307 | MCF-7 Breast | 118 / 18302 (0.6%) | 6750 / 183020 (3.7%) | −147.8 | −145.8 | 0.17 |
| FOXA1 SRX5203294 | MCF-7 Breast | 114 / 18302 (0.6%) | 6665 / 183020 (3.6%) | −147.7 | −145.8 | 0.17 |
| JUND SRX092301 | K-562 Blood | 575 / 18302 (3.1%) | 14472 / 183020 (7.9%) | −147.7 | −145.7 | 0.40 |
| ZNF711 SRX7805363 | 293 Kidney | 1581 / 18302 (8.6%) | 7400 / 183020 (4.0%) | −147.4 | −145.5 | 2.14 |
| JUN SRX883584 | MDA-MB-231 Breast | 691 / 18302 (3.8%) | 16159 / 183020 (8.8%) | −147.3 | −145.3 | 0.43 |
| ARID5B SRX10475139 | Hep G2 Liver | 477 / 18302 (2.6%) | 12965 / 183020 (7.1%) | −147.2 | −145.3 | 0.37 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 470 / 18302 (2.6%) | 12852 / 183020 (7.0%) | −147.2 | −145.2 | 0.37 |
| FOXA1 SRX1161203 | T-47D Breast | 313 / 18302 (1.7%) | 10323 / 183020 (5.6%) | −147.1 | −145.2 | 0.30 |
| FOXA1 SRX5323845 | MCF-7 Breast | 152 / 18302 (0.8%) | 7409 / 183020 (4.0%) | −146.8 | −144.8 | 0.21 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 760 / 18302 (4.2%) | 17123 / 183020 (9.4%) | −146.7 | −144.7 | 0.44 |
| FOXA1 SRX190181 | A549 Lung | 316 / 18302 (1.7%) | 10359 / 183020 (5.7%) | −146.6 | −144.7 | 0.31 |
| EP300 SRX1012644 | MCF-7 Breast | 188 / 18302 (1.0%) | 8098 / 183020 (4.4%) | −146.5 | −144.6 | 0.23 |
| SMARCA4 SRX5212371 | Mel270 Others | 624 / 18302 (3.4%) | 15147 / 183020 (8.3%) | −146.4 | −144.4 | 0.41 |
| FOS SRX3322637 | MCF-7 Breast | 226 / 18302 (1.2%) | 8791 / 183020 (4.8%) | −146.4 | −144.4 | 0.26 |
| EP300 ERX626811 | U-937 Blood | 1257 / 18302 (6.9%) | 5264 / 183020 (2.9%) | −146.2 | −144.3 | 2.39 |
| RBFOX2 SRX4708082 | K-562 Blood | 2418 / 18302 (13.2%) | 13530 / 183020 (7.4%) | −146.0 | −144.1 | 1.79 |
| FOXA1 SRX3923515 | MCF-7 Breast | 242 / 18302 (1.3%) | 9059 / 183020 (4.9%) | −145.9 | −144.0 | 0.27 |
| ESR1 SRX3123829 | MCF-7 Breast | 251 / 18302 (1.4%) | 9221 / 183020 (5.0%) | −145.9 | −144.0 | 0.27 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 289 / 18302 (1.6%) | 9873 / 183020 (5.4%) | −145.8 | −143.8 | 0.29 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 229 / 18302 (1.3%) | 125 / 183020 (0.1%) | −145.7 | −143.7 | 18.32 |
| ESR1 SRX2912055 | MCF-7 Breast | 163 / 18302 (0.9%) | 7590 / 183020 (4.1%) | −145.6 | −143.7 | 0.21 |
| ZNF711 SRX7805362 | 293 Kidney | 1502 / 18302 (8.2%) | 6900 / 183020 (3.8%) | −145.6 | −143.7 | 2.18 |
| ESR1 SRX20282938 | MCF-7 Breast | 355 / 18302 (1.9%) | 10965 / 183020 (6.0%) | −145.5 | −143.6 | 0.32 |
| NR3C1 SRX19024870 | MCF-7 Breast | 136 / 18302 (0.7%) | 7058 / 183020 (3.9%) | −145.5 | −143.6 | 0.19 |
| MECOM SRX23677890 | HNT-34 Blood | 1837 / 18302 (10.0%) | 9243 / 183020 (5.1%) | −145.4 | −143.5 | 1.99 |
| MethylCap SRX014767 | NB-4 Blood | 1763 / 18302 (9.6%) | 8727 / 183020 (4.8%) | −145.1 | −143.1 | 2.02 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 509 / 18302 (2.8%) | 13369 / 183020 (7.3%) | −144.9 | −142.9 | 0.38 |
| ESR1 SRX1469949 | MCF-7 Breast | 250 / 18302 (1.4%) | 9166 / 183020 (5.0%) | −144.8 | −142.9 | 0.27 |
| FOXA1 SRX5323830 | T-47D Breast | 258 / 18302 (1.4%) | 9302 / 183020 (5.1%) | −144.7 | −142.8 | 0.28 |
| ESR1 SRX20282971 | MCF-7 Breast | 442 / 18302 (2.4%) | 12319 / 183020 (6.7%) | −144.5 | −142.6 | 0.36 |
| JUNB SRX10119383 | MCF 10A Breast | 305 / 18302 (1.7%) | 10091 / 183020 (5.5%) | −144.1 | −142.2 | 0.30 |
| Epitope tags SRX2255894 | 293 Kidney | 1386 / 18302 (7.6%) | 6152 / 183020 (3.4%) | −144.1 | −142.2 | 2.25 |
| VGLL1 SRX24602130 | BT-20 Breast | 471 / 18302 (2.6%) | 12758 / 183020 (7.0%) | −144.0 | −142.1 | 0.37 |
| ERG SRX063922 | K-562 Blood | 1582 / 18302 (8.6%) | 7489 / 183020 (4.1%) | −143.7 | −141.8 | 2.11 |
| ESR1 SRX330068 | MCF-7 Breast | 204 / 18302 (1.1%) | 8305 / 183020 (4.5%) | −143.7 | −141.8 | 0.25 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 385 / 18302 (2.1%) | 11389 / 183020 (6.2%) | −143.6 | −141.7 | 0.34 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 520 / 18302 (2.8%) | 13475 / 183020 (7.4%) | −143.2 | −141.3 | 0.39 |
| NANOG SRX10445309 | Neural crest cells Neural | 248 / 18302 (1.4%) | 9072 / 183020 (5.0%) | −143.0 | −141.1 | 0.27 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 520 / 18302 (2.8%) | 13465 / 183020 (7.4%) | −142.9 | −141.0 | 0.39 |
| FOS SRX070879 | HUVEC Cardiovascular | 473 / 18302 (2.6%) | 12746 / 183020 (7.0%) | −142.9 | −141.0 | 0.37 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 115 / 18302 (0.6%) | 6543 / 183020 (3.6%) | −142.7 | −140.8 | 0.18 |
| ESR1 SRX10365558 | MCF-7 Breast | 302 / 18302 (1.7%) | 9992 / 183020 (5.5%) | −142.7 | −140.8 | 0.30 |
| ESR1 SRX4451212 | MCF-7 Breast | 427 / 18302 (2.3%) | 12008 / 183020 (6.6%) | −142.4 | −140.5 | 0.36 |
| EP300 SRX176883 | MCF-7 Breast | 202 / 18302 (1.1%) | 8229 / 183020 (4.5%) | −142.4 | −140.4 | 0.25 |
| FOXA1 SRX5323846 | MCF-7 Breast | 164 / 18302 (0.9%) | 7515 / 183020 (4.1%) | −142.3 | −140.4 | 0.22 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 290 / 18302 (1.6%) | 9770 / 183020 (5.3%) | −142.2 | −140.3 | 0.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 301 / 18302 (1.6%) | 9957 / 183020 (5.4%) | −142.1 | −140.2 | 0.30 |
| ESR1 SRX10365534 | MCF-7 Breast | 126 / 18302 (0.7%) | 6753 / 183020 (3.7%) | −142.1 | −140.2 | 0.19 |
| DAXX SRX1021630 | PC-3 Prostate | 456 / 18302 (2.5%) | 12452 / 183020 (6.8%) | −142.0 | −140.1 | 0.37 |
| AR SRX1067068 | LHSAR Prostate | 534 / 18302 (2.9%) | 13641 / 183020 (7.5%) | −142.0 | −140.1 | 0.39 |
| ESR1 SRX5323873 | MCF-7 Breast | 555 / 18302 (3.0%) | 13949 / 183020 (7.6%) | −141.8 | −139.9 | 0.40 |
| RELA SRX5938177 | FaDu Others | 412 / 18302 (2.3%) | 11751 / 183020 (6.4%) | −141.7 | −139.8 | 0.35 |
| FOXA1 SRX6860635 | T-47D Breast | 335 / 18302 (1.8%) | 10504 / 183020 (5.7%) | −141.6 | −139.7 | 0.32 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 365 / 18302 (2.0%) | 10991 / 183020 (6.0%) | −141.5 | −139.7 | 0.33 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1068 / 18302 (5.8%) | 4155 / 183020 (2.3%) | −141.5 | −139.6 | 2.57 |
| AR SRX9109113 | MDA-MB-453 Breast | 847 / 18302 (4.6%) | 18126 / 183020 (9.9%) | −141.4 | −139.5 | 0.47 |
| FOXA1 SRX1447316 | MCF-7 Breast | 185 / 18302 (1.0%) | 7884 / 183020 (4.3%) | −141.4 | −139.5 | 0.23 |
| GATAD2A SRX2636507 | Hep G2 Liver | 485 / 18302 (2.6%) | 12869 / 183020 (7.0%) | −141.3 | −139.4 | 0.38 |
| FOXA1 SRX9604645 | LNCAP Prostate | 631 / 18302 (3.4%) | 15049 / 183020 (8.2%) | −141.2 | −139.3 | 0.42 |
| FOXA1 SRX6878604 | LNCAP Prostate | 363 / 18302 (2.0%) | 10948 / 183020 (6.0%) | −141.2 | −139.3 | 0.33 |
| AR SRX15946405 | MDA-MB-453 Breast | 282 / 18302 (1.5%) | 9597 / 183020 (5.2%) | −141.1 | −139.2 | 0.29 |
| CEBPB SRX190345 | MCF-7 Breast | 350 / 18302 (1.9%) | 10727 / 183020 (5.9%) | −140.9 | −139.1 | 0.33 |
| ESR1 SRX20282959 | MCF-7 Breast | 183 / 18302 (1.0%) | 7828 / 183020 (4.3%) | −140.8 | −138.9 | 0.23 |
| ESR1 SRX792933 | LY2 Breast | 370 / 18302 (2.0%) | 11048 / 183020 (6.0%) | −140.8 | −138.9 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 390 / 18302 (2.1%) | 11368 / 183020 (6.2%) | −140.8 | −138.9 | 0.34 |
| FOXA1 SRX190282 | A549 Lung | 313 / 18302 (1.7%) | 10111 / 183020 (5.5%) | −140.7 | −138.8 | 0.31 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 304 / 18302 (1.7%) | 9949 / 183020 (5.4%) | −140.4 | −138.5 | 0.31 |
| ESR1 SRX20282953 | MCF-7 Breast | 373 / 18302 (2.0%) | 11082 / 183020 (6.1%) | −140.4 | −138.5 | 0.34 |
| ESR1 SRX1012633 | MCF-7 Breast | 230 / 18302 (1.3%) | 8672 / 183020 (4.7%) | −140.3 | −138.4 | 0.27 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 300 / 18302 (1.6%) | 9874 / 183020 (5.4%) | −140.2 | −138.3 | 0.30 |
| AR SRX11149848 | MDA-MB-453 Breast | 284 / 18302 (1.6%) | 9604 / 183020 (5.2%) | −140.1 | −138.3 | 0.30 |
| NR3C1 SRX1161167 | MCF-7 Breast | 110 / 18302 (0.6%) | 6364 / 183020 (3.5%) | −140.1 | −138.3 | 0.17 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 465 / 18302 (2.5%) | 12518 / 183020 (6.8%) | −140.1 | −138.2 | 0.37 |
| FOXA1 SRX219284 | LNCAP Prostate | 612 / 18302 (3.3%) | 14715 / 183020 (8.0%) | −139.8 | −137.9 | 0.42 |
| RORC SRX5359053 | HCC70 Breast | 1258 / 18302 (6.9%) | 5394 / 183020 (2.9%) | −139.8 | −137.9 | 2.33 |
| KAT6A DRX366109 | 293 Kidney | 2100 / 18302 (11.5%) | 11320 / 183020 (6.2%) | −139.8 | −137.9 | 1.86 |
| FOXA1 SRX1161205 | T-47D Breast | 236 / 18302 (1.3%) | 8758 / 183020 (4.8%) | −139.7 | −137.9 | 0.27 |
| ESR1 SRX8537723 | MCF-7 Breast | 367 / 18302 (2.0%) | 10960 / 183020 (6.0%) | −139.6 | −137.7 | 0.33 |
| ESR1 SRX1012630 | MCF-7 Breast | 168 / 18302 (0.9%) | 7506 / 183020 (4.1%) | −139.6 | −137.7 | 0.22 |
| FOXA1 SRX3931073 | MCF-7 Breast | 269 / 18302 (1.5%) | 9322 / 183020 (5.1%) | −139.4 | −137.5 | 0.29 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 162 / 18302 (0.9%) | 7384 / 183020 (4.0%) | −139.4 | −137.5 | 0.22 |
| NFIL3 SRX2630334 | Hep G2 Liver | 360 / 18302 (2.0%) | 10832 / 183020 (5.9%) | −139.3 | −137.4 | 0.33 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 402 / 18302 (2.2%) | 11506 / 183020 (6.3%) | −139.2 | −137.4 | 0.35 |
| MYC SRX13134693 | 293 Kidney | 1333 / 18302 (7.3%) | 5900 / 183020 (3.2%) | −139.2 | −137.3 | 2.26 |
| KAT6A DRX366108 | 293 Kidney | 1744 / 18302 (9.5%) | 8737 / 183020 (4.8%) | −139.2 | −137.3 | 2.00 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 352 / 18302 (1.9%) | 10691 / 183020 (5.8%) | −138.9 | −137.0 | 0.33 |
| FOXA1 SRX3931031 | MCF-7 Breast | 214 / 18302 (1.2%) | 8328 / 183020 (4.6%) | −138.7 | −136.8 | 0.26 |
| MECOM SRX23677891 | HNT-34 Blood | 1814 / 18302 (9.9%) | 9256 / 183020 (5.1%) | −138.5 | −136.7 | 1.96 |
| JUN SRX2355072 | HAEC Cardiovascular | 598 / 18302 (3.3%) | 14458 / 183020 (7.9%) | −138.5 | −136.6 | 0.41 |
| KMT2C SRX1787675 | MCF-7 Breast | 402 / 18302 (2.2%) | 11471 / 183020 (6.3%) | −138.3 | −136.4 | 0.35 |
| VGLL1 SRX18013277 | FULVR Breast | 196 / 18302 (1.1%) | 7989 / 183020 (4.4%) | −138.2 | −136.4 | 0.25 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 583 / 18302 (3.2%) | 1485 / 183020 (0.8%) | −138.1 | −136.2 | 3.93 |
| NCOA3 SRX4663589 | MCF-7 Breast | 124 / 18302 (0.7%) | 6595 / 183020 (3.6%) | −138.0 | −136.2 | 0.19 |
| ING2 SRX286201 | RKO Digestive tract | 1429 / 18302 (7.8%) | 6574 / 183020 (3.6%) | −137.8 | −135.9 | 2.17 |
| GATA3 SRX100559 | T-47D Breast | 504 / 18302 (2.8%) | 13030 / 183020 (7.1%) | −137.8 | −135.9 | 0.39 |
| NABP2 SRX9523535 | HT-1080 Bone | 1383 / 18302 (7.6%) | 6263 / 183020 (3.4%) | −137.7 | −135.9 | 2.21 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1662 / 18302 (9.1%) | 8192 / 183020 (4.5%) | −137.7 | −135.9 | 2.03 |
| KMT2A SRX2281249 | SEM Blood | 1955 / 18302 (10.7%) | 10308 / 183020 (5.6%) | −137.7 | −135.8 | 1.90 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 125 / 18302 (0.7%) | 6604 / 183020 (3.6%) | −137.6 | −135.7 | 0.19 |
| NR3C1 SRX8520802 | HCC1187 Breast | 339 / 18302 (1.9%) | 10432 / 183020 (5.7%) | −137.6 | −135.7 | 0.32 |
| ESR1 SRX5323878 | MCF-7 Breast | 462 / 18302 (2.5%) | 12377 / 183020 (6.8%) | −137.5 | −135.6 | 0.37 |
| JUNB SRX10119384 | MCF 10A Breast | 280 / 18302 (1.5%) | 9448 / 183020 (5.2%) | −137.5 | −135.6 | 0.30 |
| ERG SRX063921 | K-562 Blood | 1488 / 18302 (8.1%) | 6986 / 183020 (3.8%) | −137.4 | −135.5 | 2.13 |
| FOXA2 SRX10475773 | Hep G2 Liver | 559 / 18302 (3.1%) | 13840 / 183020 (7.6%) | −137.3 | −135.5 | 0.40 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 442 / 18302 (2.4%) | 12050 / 183020 (6.6%) | −137.0 | −135.2 | 0.37 |
| WWTR1 SRX10119367 | MCF 10A Breast | 538 / 18302 (2.9%) | 13507 / 183020 (7.4%) | −136.8 | −135.0 | 0.40 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1244 / 18302 (6.8%) | 5358 / 183020 (2.9%) | −136.8 | −135.0 | 2.32 |
| NR3C1 SRX19024880 | MCF-7 Breast | 112 / 18302 (0.6%) | 6304 / 183020 (3.4%) | −136.5 | −134.7 | 0.18 |
| TRPS1 SRX3401273 | MCF-7 Breast | 152 / 18302 (0.8%) | 7090 / 183020 (3.9%) | −135.9 | −134.1 | 0.21 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 324 / 18302 (1.8%) | 10123 / 183020 (5.5%) | −135.8 | −133.9 | 0.32 |
| ZEB1 SRX13298924 | MCF-7 Breast | 221 / 18302 (1.2%) | 8363 / 183020 (4.6%) | −135.8 | −133.9 | 0.26 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 463 / 18302 (2.5%) | 12320 / 183020 (6.7%) | −135.4 | −133.6 | 0.38 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 645 / 18302 (3.5%) | 15011 / 183020 (8.2%) | −135.1 | −133.3 | 0.43 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1912 / 18302 (10.4%) | 10066 / 183020 (5.5%) | −134.9 | −133.1 | 1.90 |
| ESR1 SRX2513521 | MCF-7 Breast | 219 / 18302 (1.2%) | 8293 / 183020 (4.5%) | −134.6 | −132.7 | 0.26 |
| EP300 SRX2194265 | SUM 159PT Breast | 731 / 18302 (4.0%) | 16217 / 183020 (8.9%) | −134.5 | −132.7 | 0.45 |
| AR SRX9469987 | LAPC-4 Prostate | 213 / 18302 (1.2%) | 8180 / 183020 (4.5%) | −134.5 | −132.7 | 0.26 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 294 / 18302 (1.6%) | 9580 / 183020 (5.2%) | −134.4 | −132.6 | 0.31 |
| FOS SRX150664 | HUVEC Cardiovascular | 605 / 18302 (3.3%) | 14400 / 183020 (7.9%) | −134.3 | −132.5 | 0.42 |
| FOXA1 SRX2642368 | VCaP Prostate | 562 / 18302 (3.1%) | 13763 / 183020 (7.5%) | −134.3 | −132.4 | 0.41 |
| FOXA3 SRX2630190 | Hep G2 Liver | 387 / 18302 (2.1%) | 11091 / 183020 (6.1%) | −134.2 | −132.4 | 0.35 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 264 / 18302 (1.4%) | 9066 / 183020 (5.0%) | −134.2 | −132.4 | 0.29 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 184 / 18302 (1.0%) | 7645 / 183020 (4.2%) | −134.2 | −132.4 | 0.24 |
| SOX5 SRX2636544 | Hep G2 Liver | 465 / 18302 (2.5%) | 12301 / 183020 (6.7%) | −134.2 | −132.3 | 0.38 |
| FOXA1 SRX3923511 | MCF-7 Breast | 176 / 18302 (1.0%) | 7486 / 183020 (4.1%) | −133.9 | −132.1 | 0.24 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 562 / 18302 (3.1%) | 1425 / 183020 (0.8%) | −133.8 | −131.9 | 3.94 |
| EOMES SRX035159 | hESC derived mesendodermal cells Pluripotent stem cell | 312 / 18302 (1.7%) | 9851 / 183020 (5.4%) | −133.6 | −131.7 | 0.32 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 621 / 18302 (3.4%) | 14593 / 183020 (8.0%) | −133.4 | −131.6 | 0.43 |
| TLE3 SRX4815194 | SUM 149PT Breast | 357 / 18302 (2.0%) | 10575 / 183020 (5.8%) | −133.3 | −131.5 | 0.34 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 147 / 18302 (0.8%) | 6914 / 183020 (3.8%) | −133.2 | −131.4 | 0.21 |
| EP300 SRX10976215 | A549 Lung | 441 / 18302 (2.4%) | 11893 / 183020 (6.5%) | −133.1 | −131.3 | 0.37 |
Showing first 500 of 17580 rows.